Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Xanthus Pharmaceuticals
company
About
Xanthus is a biopharmaceutical company.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $25M
- Industries
- Biopharma,Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2001
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Xanthus Pharmaceuticals Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, acquisition, and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$55.80M
Xanthus Pharmaceuticals has raised a total of
$55.80M
in funding over 2 rounds. Their latest funding was raised on
Dec 1, 2006 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 1, 2006 | Series B | $25M | 1 | — | — | Detail |
| Dec 12, 2003 | Series B | $30.80M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Xanthus Pharmaceuticals is funded by 1 investors.
CDP Capital Technology Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
CDP Capital Technology Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
